
It's been a busy week for the Contemporary OB/GYN® team.
Associate Editor for Contemporary OB/GYN. You can reach her a lcarr@mjhlifesciences.com.

It's been a busy week for the Contemporary OB/GYN® team.


Here's what's coming up this week on Contemporary OB/GYN®

Here's what you missed this week from Contemporary OB/GYN.

In this episode of Pap Talk, Gloria A. Bachmann, MD, MMS sat down with Michael Krychman, MD, at the North American Menopause Society (NAMS) Annual Meeting to talk about telemedicine and her work providing trauma-informed care to women in prison.

A look at what's coming to Contemporary OB/GYN® this week

What you missed this week on Contemporary OB/GYN®

Vice President Kamala Harris hosted the White House’s first-ever Maternal Health Day of Action Summit on Dec. 7. During the Summit, Harris outlined the administration’s new initiatives and issued a nationwide call to action for public and private sectors to help improve maternal health outcomes.

COVIDmenses is recruiting participants for a study to examine potential effects of COVID-19 vaccination on menstrual health.

Here's what's coming up this week on Contemporary OB/GYN.

Wondering what you missed this week?

In this episode of Pap Talk, we took you with us to the North American Menopause Society's recent Annual Meeting. Sexual health specialist Michael Krychman, MD, sat down with Brooke Faught, NP, to learn more about her work at the Women's Institute for Sexual Health, her role on the NAMS Planning Committee, and her tips for talking trauma with patients.

Here's what's coming to Contemporary OB/GYN this week.

Here's what's coming up this week on Contemporary OB/GYN.

It was a busy week for the Contemporary OB/GYN team.

At AAGL’s 50th Global Congress on MIGS, Peter L. Rosenblatt, MD, and Cheryl B. Iglesia, MD, FACOG, debated the use of native tissue repair and transvaginal mesh in pelvic reconstructive surgery.

“My hysteroscope is my stethoscope. I use it in every opportunity when the story doesn’t match,” Linda D. Bradley, MD, said during her presentation at AAGL’s 50th Global Congress on MIGS, “Office Hysteroscopy: Seeing is Believing. A Manifesto for Change.”

“If you want to provide comprehensive care, it is truly impossible as 1 person,” began Jean Uy-Kroh, MD, FACOG, director, Chronic Pelvic Pain Program at the Cleveland Clinic in Cleveland, Ohio, at AAGL’s 50th Global Congress on MIGS in Austin, Texas.


Hear from Mauricio S. Abrão, MD, PhD, 2021 scientific program chair and upcoming president of AAGL, and Executive Director Linda Michels, discuss key topics and critical updates at AAGL 2021 you don’t want to miss.

The American Association of Gynecologic Laparoscopists (AAGL) 50th Global Congress on minimally invasive gynecologic surgery (MIGS) begins today and continues through Wednesday, November 17 in Austin, Texas. Follow along for the latest coverage.

The week in review from Contemporary OB/GYN®

Margo B. Minissian, PhD, shares key updates from the newest recommendations for primary prevention of cardiovascular disease in women from the ACC and AHA. Minissian is executive director, Geri & Richard Brawerman Nursing Institute at Cedars-Sinai Medical Center and the Simms/ Mann Endowed Chair of Nursing Education, Innovation and Research at Cedars-Sinai Medical Center.

Put your knowledge to the test in honor of Prematurity Awareness Month.

Past president Sheryl Kingsberg, PhD, discusses the paper she chose to present as paper of the year at NAMS 2021.

We caught up with Risa Kagan, MD, at the North American Menopause Society's 2021 Annual Meeting to hear about her role on the Scientific Planning Committee and this year's takeaways.

What to watch for this week on Contemporary OB/GYN®

In this video, Barb Dehn, NP, discusses Brexafemme, the first fungicidal medication approved for the treatment of vulvovaginal candidiasis.

In this interview, Steven R. Goldstein, MD, shares updated research on evaluating the uterus in women with perimenopausal and postmenopausal bleeding.

Disparities across the globe continue to surface as we approach year 2 of the COVID-19 pandemic, especially in health care. As one considers its implications, a research team from the American Cancer Society investigated its potential impact on early cancer detection.